ZIVO Bioscience (ZIVO) Competitors

SOPHiA GENETICS (NASDAQ:SOPH) and ZIVO Bioscience (NASDAQ:ZIVO) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, dividends, media sentiment, earnings, community ranking, analyst recommendations, profitability and risk.

Do analysts prefer SOPH or ZIVO?

SOPHiA GENETICS presently has a consensus target price of $6.80, indicating a potential upside of 132.08%. Given SOPHiA GENETICS's stronger consensus rating and higher probable upside, analysts plainly believe SOPHiA GENETICS is more favorable than ZIVO Bioscience.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SOPHiA GENETICS	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75
ZIVO Bioscience	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Do institutionals & insiders believe in SOPH or ZIVO?

31.6% of SOPHiA GENETICS shares are owned by institutional investors. Comparatively, 12.8% of ZIVO Bioscience shares are owned by institutional investors. 4.9% of SOPHiA GENETICS shares are owned by insiders. Comparatively, 21.5% of ZIVO Bioscience shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Does the media favor SOPH or ZIVO?

In the previous week, SOPHiA GENETICS had 5 more articles in the media than ZIVO Bioscience. MarketBeat recorded 7 mentions for SOPHiA GENETICS and 2 mentions for ZIVO Bioscience. ZIVO Bioscience's average media sentiment score of 0.64 beat SOPHiA GENETICS's score of -0.05 indicating that ZIVO Bioscience is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SOPHiA GENETICS	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
ZIVO Bioscience	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Does the MarketBeat Community believe in SOPH or ZIVO?

ZIVO Bioscience received 80 more outperform votes than SOPHiA GENETICS when rated by MarketBeat users. However, 70.37% of users gave SOPHiA GENETICS an outperform vote while only 60.74% of users gave ZIVO Bioscience an outperform vote.

Company	Underperform	Outperform
SOPHiA GENETICS	Outperform Votes 19 70.37%	Underperform Votes 8 29.63%
ZIVO Bioscience	Outperform Votes 99 60.74%	Underperform Votes 64 39.26%

Which has more volatility & risk, SOPH or ZIVO?

SOPHiA GENETICS has a beta of 1.03, suggesting that its stock price is 3% more volatile than the S&P 500. Comparatively, ZIVO Bioscience has a beta of 0.03, suggesting that its stock price is 97% less volatile than the S&P 500.

Which has higher earnings & valuation, SOPH or ZIVO?

ZIVO Bioscience has lower revenue, but higher earnings than SOPHiA GENETICS. ZIVO Bioscience is trading at a lower price-to-earnings ratio than SOPHiA GENETICS, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SOPHiA GENETICS	$67.17M	2.91	-$78.98M	-$1.00	-2.93
ZIVO Bioscience	$15.85K	3,839.46	-$7.78M	-$4.28	-3.73

Is SOPH or ZIVO more profitable?

ZIVO Bioscience has a net margin of 0.00% compared to SOPHiA GENETICS's net margin of -110.71%. ZIVO Bioscience's return on equity of 0.00% beat SOPHiA GENETICS's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SOPHiA GENETICS	-110.71%	-55.06%	-38.33%
ZIVO Bioscience	N/A	N/A	-2,240.92%

Summary

SOPHiA GENETICS beats ZIVO Bioscience on 11 of the 18 factors compared between the two stocks.